{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:06:40Z","timestamp":1747973200168,"version":"3.41.0"},"reference-count":2,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00482-025-00882-w","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:47:17Z","timestamp":1747903637000},"page":"165-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EMA pr\u00fcft Metamizol: st\u00e4rkerer Fokus auf Agranulozytose\u00a0\u2013 aber auch etablierter Nutzen in der Versorgung","European Medicines Agency checks metamizole: stronger focus on agranulocytosis but also established use in treatment"],"prefix":"10.1007","volume":"39","author":[{"given":"Claudia","family":"Bausewein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Petzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"2","key":"882_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2015","unstructured":"Huber\u00a0M, Andersohn\u00a0F, Sarganas\u00a0G, Bronder\u00a0E, Klimpel\u00a0A, Thomae\u00a0M et\u00a0al (2015) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 71(2):219\u2013227. https:\/\/doi.org\/10.1007\/s00228-014-1777-8","journal-title":"Eur J Clin Pharmacol"},{"key":"882_CR2","unstructured":"Metamizolhaltige Arzneimittel: Wichtige Ma\u00dfnahmen zur Minimierung der schwerwiegenden Folgen des bekannten Risikos f\u00fcr Agranulozytose. Rote Hand Brief 09.12.2024. https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2024\/rhb-metamizol.html. Zugegriffen: 1. Apr. 2025"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-025-00882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-025-00882-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-025-00882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:47:22Z","timestamp":1747903642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-025-00882-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":2,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1007\/s00482-025-00882-w","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"30 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Bausewein und F.\u00a0Petzke geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}